APA (7th ed.) Citation

Bengtsson, E., Nerjovaj, P., Wangefjord, S., Nodin, B., Eberhard, J., Uhlén, M., . . . Jirström, K. (2014). HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome. Diagnostic Pathology, 9(1), 1. https://doi.org/10.1186/1746-1596-9-78

Chicago Style (17th ed.) Citation

Bengtsson, Erik, Pashtrik Nerjovaj, Sakarias Wangefjord, Björn Nodin, Jakob Eberhard, Mathias Uhlén, Signe Borgquist, and Karin Jirström. "HMG-CoA Reductase Expression in Primary Colorectal Cancer Correlates with Favourable Clinicopathological Characteristics and an Improved Clinical Outcome." Diagnostic Pathology 9, no. 1 (2014): 1. https://doi.org/10.1186/1746-1596-9-78.

MLA (9th ed.) Citation

Bengtsson, Erik, et al. "HMG-CoA Reductase Expression in Primary Colorectal Cancer Correlates with Favourable Clinicopathological Characteristics and an Improved Clinical Outcome." Diagnostic Pathology, vol. 9, no. 1, 2014, p. 1, https://doi.org/10.1186/1746-1596-9-78.